Works matching IS 15246175 AND DT 2023 AND VI 25 AND IP 9
Results: 12
Retraction Statement: Predictive validity of a medication adherence measure in an outpatient setting.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 889, doi. 10.1111/jch.14718
- Publication type:
- Article
Global cardiovascular diseases burden attributable to high sodium intake from 1990 to 2019.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 868, doi. 10.1111/jch.14717
- By:
- Publication type:
- Article
Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 828, doi. 10.1111/jch.14715
- By:
- Publication type:
- Article
Geriatric sarcopenia is associated with hypertension: A systematic review and meta‐analysis.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 808, doi. 10.1111/jch.14714
- By:
- Publication type:
- Article
Notification.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 890, doi. 10.1111/jch.14712
- Publication type:
- Article
Prevalence and risk factors of pre‐hypertension and high blood pressure among adolescents in Cameroonian schools.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 845, doi. 10.1111/jch.14711
- By:
- Publication type:
- Article
Amlodipine in the current management of hypertension.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 801, doi. 10.1111/jch.14709
- By:
- Publication type:
- Article
Efficacy of γ‐linolenic acid, Vitis vinifera extract, and acetyl‐L‐carnitine combination therapy for improving arterial stiffness in Korean adults: Real‐world evidence.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 880, doi. 10.1111/jch.14708
- By:
- Publication type:
- Article
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 817, doi. 10.1111/jch.14707
- By:
- Publication type:
- Article
Computed tomographic manifestations of celiac ganglia between hypertensive and non‐hypertensive population.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 853, doi. 10.1111/jch.14706
- By:
- Publication type:
- Article
Rationale and design of a multicenter randomized study comparing the efficacy and safety of esaxerenone versus trichlormethiazide in patients with uncontrolled essential hypertension: EXCITE‐HT study.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 861, doi. 10.1111/jch.14705
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Clinical Hypertension, 2023, v. 25, n. 9, p. 797, doi. 10.1111/jch.14511
- Publication type:
- Article